According to the latest analysis by DataM Intelligence, the Next-Generation Multiple Myeloma Therapies Market Size was valued ...

In reviewing the current state of evidence, several points stand out. The strongest findings show that low doses of ketamine ...

Ad hoc announcement pursuant to Art. 53 LRComparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth ...

A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, ...

A malaria test commonly used across Asia and South America “is not fit for purpose”, researchers have claimed.

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...

Prior authorizations (PAs) continue to be one of the biggest hurdles to timely patient care. A recent survey found that 93% of physicians say that the PA process can delay treatment and three-quarters ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

Cardiologists need to know how to recognize and manage the cardiac effects that can arise from SARS-CoV-2 infections or COVID ...

Artificial Intelligence, or AI, is now transforming how we detect, prevent and treat illness, promising earlier interventions, smarter therapies and more affordable care for everyone.​ ...